Maravai LifeSciences Holdings, Inc. (MRVI)
USD 2.07
(1.97%)
USD 2.07
(1.97%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 697.56 Million USD | -49.34% |
| 2022 | 1.37 Billion USD | 0.3% |
| 2021 | 1.37 Billion USD | 23.03% |
| 2020 | 1.11 Billion USD | 157.62% |
| 2019 | 433.16 Million USD | 10.6% |
| 2018 | 391.66 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 667.25 Million USD | -4.35% |
| 2024 Q2 | 671.19 Million USD | 0.59% |
| 2023 Q1 | 1.41 Billion USD | 2.74% |
| 2023 FY | 697.56 Million USD | -49.34% |
| 2023 Q4 | 697.56 Million USD | -49.28% |
| 2023 Q3 | 1.37 Billion USD | 0.62% |
| 2023 Q2 | 1.36 Billion USD | -3.39% |
| 2022 Q4 | 1.37 Billion USD | -2.14% |
| 2022 Q1 | 1.38 Billion USD | 1.17% |
| 2022 FY | 1.37 Billion USD | 0.3% |
| 2022 Q2 | 1.39 Billion USD | 0.65% |
| 2022 Q3 | 1.4 Billion USD | 0.66% |
| 2021 Q3 | 1.44 Billion USD | 13.64% |
| 2021 Q1 | 1.14 Billion USD | 2.34% |
| 2021 Q4 | 1.37 Billion USD | -4.73% |
| 2021 Q2 | 1.26 Billion USD | 11.04% |
| 2021 FY | 1.37 Billion USD | 23.03% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q3 | 702.11 Million USD | 0.0% |
| 2020 Q4 | 1.11 Billion USD | 58.94% |
| 2020 FY | 1.11 Billion USD | 157.62% |
| 2019 Q4 | 433.16 Million USD | 0.0% |
| 2019 FY | 433.16 Million USD | 10.6% |
| 2018 FY | 391.66 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -746.222% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2371.36% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -4189.282% |
| Autolus Therapeutics plc | 263.9 Million USD | -164.323% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -236840.144% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -10238.906% |
| Shattuck Labs, Inc. | 14.85 Million USD | -4594.569% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -14211.982% |
| CervoMed Inc. | 2.59 Million USD | -26773.42% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -845.634% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1883.011% |
| Aptose Biosciences Inc. | 15.8 Million USD | -4312.545% |
| Precision BioSciences, Inc. | 140.92 Million USD | -395.009% |
| Dyadic International, Inc. | 2.34 Million USD | -29702.222% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -475.16% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -16777.958% |
| Nektar Therapeutics | 267.04 Million USD | -161.216% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -176.157% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -7694.034% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -685.008% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -5399.574% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -97.691% |
| GRI Bio, Inc. | 2.69 Million USD | -25764.516% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -86063.405% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2143.627% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -13713.188% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -5662.77% |
| IGM Biosciences, Inc. | 220.17 Million USD | -216.821% |
| INmune Bio, Inc. | 18.86 Million USD | -3598.261% |
| Opthea Limited | 264.6 Million USD | -163.629% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1093.338% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -376.642% |
| Verastem, Inc. | 71.18 Million USD | -879.934% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1318.509% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1708.196% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1325.582% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -433.687% |
| NextCure, Inc. | 14.99 Million USD | -4551.37% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -19668.217% |
| Organovo Holdings, Inc. | 2.74 Million USD | -25284.498% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -222155.287% |
| Arvinas, Inc. | 644.6 Million USD | -8.217% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1140.561% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1265.02% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2048.142% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -450.457% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -362.304% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -360.403% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1226.903% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -26653.882% |
| Apollomics, Inc. | 14.15 Million USD | -4828.75% |
| PureTech Health plc | 125.58 Million USD | -455.462% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -10347.297% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2435.589% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -285.848% |
| Synaptogenix, Inc. | 5.52 Million USD | -12515.425% |
| ChromaDex Corporation | 26.5 Million USD | -2531.53% |
| Beam Therapeutics Inc. | 478.38 Million USD | -45.817% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -39593.227% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -156.188% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -325.226% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -17.394% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -42863.73% |
| Gritstone bio, Inc. | 125.91 Million USD | -453.98% |
| Mesoblast Limited | 188.79 Million USD | -269.477% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -8966.335% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -100.692% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -406.216% |
| MediWound Ltd. | 27.18 Million USD | -2465.807% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -435.724% |
| Fortress Biotech, Inc. | 165.93 Million USD | -320.375% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -73.838% |
| Achilles Therapeutics plc | 19.08 Million USD | -3554.665% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -72.898% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3685.976% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -13222.498% |
| Zai Lab Limited | 240.17 Million USD | -190.438% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -42023.551% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -633.685% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -573.782% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -907.519% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -26558.509% |
| FibroGen, Inc. | 585.72 Million USD | -19.094% |
| Celcuity Inc. | 51.45 Million USD | -1255.811% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3912.921% |
| ContextLogic Inc. | 206 Million USD | -238.624% |
| GH Research PLC | 6.7 Million USD | -10309.879% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -875.89% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -8408.978% |
| ImmuCell Corporation | 18.81 Million USD | -3607.494% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -730.218% |
| Amarin Corporation plc | 279.58 Million USD | -149.499% |
| TG Therapeutics, Inc. | 169.08 Million USD | -312.553% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -5427.026% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4653.107% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -92.111% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2494.725% |
| Aptorum Group Limited | 5.25 Million USD | -13169.94% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 42.615% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 28.27% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -13434.38% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -45.815% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -19667.309% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2552.947% |
| Ardelyx, Inc. | 130.76 Million USD | -433.458% |
| Ainos, Inc. | 7.39 Million USD | -9333.932% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1211.707% |
| Prothena Corporation plc | 135.01 Million USD | -416.65% |
| HilleVax, Inc. | 78.9 Million USD | -784.013% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -186.943% |
| Celularity Inc. | 102.92 Million USD | -577.716% |
| Rallybio Corporation | 9.43 Million USD | -7292.603% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2753.614% |
| Omeros Corporation | 403.25 Million USD | -72.985% |
| Humacyte, Inc. | 114.67 Million USD | -508.288% |
| Immunocore Holdings plc | 228.15 Million USD | -205.738% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -14209.046% |
| Blueprint Medicines Corporation | 918.64 Million USD | 24.065% |
| IO Biotech, Inc. | 17.55 Million USD | -3873.377% |
| MEI Pharma, Inc. | 8.35 Million USD | -8249.084% |
| GT Biopharma, Inc. | 6.63 Million USD | -10416.599% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3897.055% |
| Summit Therapeutics Inc. | 125.25 Million USD | -456.908% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -35562.883% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -352.545% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -712.853% |
| Pulmatrix, Inc. | 15.96 Million USD | -4269.893% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -4322.532% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -625.43% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2734.943% |
| Acelyrin, Inc. | 86.35 Million USD | -707.807% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -178.127% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 42.38% |
| Vor Biopharma Inc. | 59.1 Million USD | -1080.235% |
| Evogene Ltd. | 17.99 Million USD | -3777.521% |
| Replimune Group, Inc. | 113.21 Million USD | -516.148% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -869.124% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1997.367% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -98847.918% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 63.071% |
| AEON Biopharma, Inc. | 159.88 Million USD | -336.281% |
| BioLineRx Ltd. | 50.7 Million USD | -1275.816% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -688.736% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1318.913% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3783.565% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -7347.059% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -459.683% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -12237.566% |
| MediciNova, Inc. | 3.89 Million USD | -17825.132% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3716.215% |
| MiMedx Group, Inc. | 96.33 Million USD | -624.142% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -46273.287% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -75.595% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 74.371% |
| Mereo BioPharma Group plc | 15.96 Million USD | -4270.167% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1088.682% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3562.148% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -845.339% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -8051.809% |
| Allakos Inc. | 74.79 Million USD | -832.662% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1118.222% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -3000.156% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -507.572% |
| NLS Pharmaceutics AG | 10.68 Million USD | -6431.392% |
| Precigen, Inc. | 41.64 Million USD | -1575.07% |
| XOMA Corporation | 145.58 Million USD | -379.163% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1972.081% |
| Incyte Corporation | 1.59 Billion USD | 56.19% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -21524.77% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -914.509% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1028.328% |
| Seer, Inc. | 39.36 Million USD | -1672.046% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -10457.538% |
| CRISPR Therapeutics AG | 346.76 Million USD | -101.162% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1451.353% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -24205.436% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -8450.68% |
| Akari Therapeutics, Plc | 4.58 Million USD | -15117.408% |
| Novavax, Inc. | 2.57 Billion USD | 72.881% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -172604.18% |
| UroGen Pharma Ltd. | 243.52 Million USD | -186.448% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -117.251% |
| Entera Bio Ltd. | 1.37 Million USD | -50484.917% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -10158.324% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -914.243% |
| Chimerix, Inc. | 19.74 Million USD | -3432.874% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3605.333% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -43.355% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1392.471% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 90.889% |
| AnaptysBio, Inc. | 364.28 Million USD | -91.489% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -15805.81% |
| Portage Biotech Inc. | 4.45 Million USD | -15575.64% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2926.317% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2536.005% |
| OKYO Pharma Limited | 7.42 Million USD | -9300.087% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -16762.434% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -84261.723% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -87370.846% |
| AbCellera Biologics Inc. | 335.77 Million USD | -107.747% |
| Genprex, Inc. | 3.25 Million USD | -21335.815% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2472.241% |
| NLS Pharmaceutics AG | 10.68 Million USD | -6431.392% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -194453.031% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2549.335% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -48207.895% |
| Bicycle Therapeutics plc | 224.41 Million USD | -210.842% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -165.844% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -3178.96% |
| Erasca, Inc. | 78.61 Million USD | -787.364% |
| bluebird bio, Inc. | 424.62 Million USD | -64.279% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -5751.082% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 63.093% |
| DBV Technologies S.A. | 42.8 Million USD | -1529.827% |
| Fortress Biotech, Inc. | 165.93 Million USD | -320.375% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -445.865% |
| CorMedix Inc. | 11.91 Million USD | -5753.278% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -18.613% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -7259.067% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2467.507% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2442.428% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1813.446% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 6.396% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1153.826% |
| Onconetix, Inc. | 23.18 Million USD | -2909.229% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -17157.942% |
| Prime Medicine, Inc. | 60.78 Million USD | -1047.69% |
| Adagene Inc. | 45.16 Million USD | -1444.335% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -163.84% |
| GlycoMimetics, Inc. | 6.9 Million USD | -10006.614% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -355.372% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -506.785% |
| SciSparc Ltd. | 1.59 Million USD | -43634.545% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -12435.117% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -717.223% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5939.532% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -823.977% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3833.688% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -176.047% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -22586.195% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 82.778% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -68221.841% |
| 2seventy bio, Inc. | 310.12 Million USD | -124.93% |
| ADMA Biologics, Inc. | 193.97 Million USD | -259.615% |
| Clene Inc. | 38.95 Million USD | -1690.881% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1830.558% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -171.452% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -266.633% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -5627.302% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -251.734% |
| Absci Corporation | 58.3 Million USD | -1096.429% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 90.185% |
| Surrozen, Inc. | 8.14 Million USD | -8464.346% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -861.272% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1834.567% |
| Cingulate Inc. | 10.36 Million USD | -6632.7% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -25266.036% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -19349.662% |
| Jaguar Health, Inc. | 45.86 Million USD | -1420.878% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -5204.684% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -119.913% |
| Kronos Bio, Inc. | 54.2 Million USD | -1186.998% |
| Innoviva, Inc. | 568.55 Million USD | -22.692% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1382.826% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -207.525% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -6218.712% |
| Soligenix, Inc. | 7.27 Million USD | -9488.663% |
| AlloVir, Inc. | 45.01 Million USD | -1449.63% |
| Century Therapeutics, Inc. | 175.94 Million USD | -296.477% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2179.776% |
| Kura Oncology, Inc. | 51.66 Million USD | -1250.25% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -10447.041% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -6554.894% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1387.379% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4751.283% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -171.978% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2518.313% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -25560.847% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -21165.532% |
| HCW Biologics Inc. | 15.05 Million USD | -4534.392% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -435.202% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -163.496% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 15.244% |
| Lantern Pharma Inc. | 2.73 Million USD | -25361.568% |
| Histogen Inc. | 5.69 Million USD | -12144.444% |
| Surrozen, Inc. | 8.14 Million USD | -8464.346% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1542.298% |
| Kodiak Sciences Inc. | 213.59 Million USD | -226.59% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -5245.704% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -6350.827% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -679.046% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4995.814% |
| Moderna, Inc. | 4.57 Billion USD | 84.743% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 73.205% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4830.492% |
| Immix Biopharma, Inc. | 3.72 Million USD | -18642.791% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -10392.87% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -310.072% |
| Exelixis, Inc. | 678.44 Million USD | -2.818% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -460.271% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -206.697% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8981.708% |
| Alkermes plc | 933.53 Million USD | 25.277% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4653.107% |
| Arcellx, Inc. | 339.75 Million USD | -105.316% |
| ESSA Pharma Inc. | 3.49 Million USD | -19858.565% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -13608.334% |
| Avid Bioservices, Inc. | 275.66 Million USD | -153.046% |
| Insmed Incorporated | 1.66 Billion USD | 58.022% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -5762.885% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -184.095% |
| Moolec Science SA | 13.94 Million USD | -4902.138% |
| RenovoRx, Inc. | 4.46 Million USD | -15519.481% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1516.532% |
| Geron Corporation | 146.12 Million USD | -377.37% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1280.444% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1028.127% |
| Royalty Pharma plc | 6.29 Billion USD | 88.923% |
| OmniAb, Inc. | 87.4 Million USD | -698.13% |
| Alector, Inc. | 487.66 Million USD | -43.041% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1653.736% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -268.778% |
| Humacyte, Inc. | 114.67 Million USD | -508.288% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2301.177% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -10.715% |
| 89bio, Inc. | 59.96 Million USD | -1063.327% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -58224.916% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2286.718% |
| Immunic, Inc. | 25.36 Million USD | -2649.787% |
| Veracyte, Inc. | 93.71 Million USD | -644.317% |
| Genelux Corporation | 8.42 Million USD | -8184.632% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -10074.533% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -106712.377% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -12234.386% |
| Immunovant, Inc. | 48.95 Million USD | -1324.913% |
| Vericel Corporation | 127.7 Million USD | -446.232% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 73.359% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2320.255% |
| XBiotech Inc. | 8.39 Million USD | -8207.324% |
| Agenus Inc. | 462.29 Million USD | -50.892% |
| Acasti Pharma Inc. | 11.55 Million USD | -5935.874% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -9075.825% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2985.52% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -25560.847% |
| Theravance Biopharma, Inc. | 169 Million USD | -312.751% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -39.394% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -11343.012% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -11466.135% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2708.802% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -10400.768% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -327.991% |
| United Therapeutics Corporation | 1.18 Billion USD | 40.994% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -187723.713% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -8051.809% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -222155.287% |
| Silo Pharma, Inc. | 1.56 Million USD | -44351.624% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -52130.069% |
| Pharming Group N.V. | 244.07 Million USD | -185.802% |
| XOMA Corporation | 145.58 Million USD | -379.163% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -10457.538% |
| Bionomics Limited | 10.15 Million USD | -6766.672% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2944.411% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1352.597% |
| uniQure N.V. | 624.01 Million USD | -11.786% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2794.585% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4814.167% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -23263.762% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2304.156% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -309.889% |
| Pluri Inc. | 34.11 Million USD | -1944.928% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -267594.362% |
| MeiraGTx Holdings plc | 319.99 Million USD | -117.996% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -808.999% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -5530.972% |
| CalciMedica, Inc. | 4.02 Million USD | -17217.925% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -151.11% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -12.928% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -53590.27% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2944.411% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1273.54% |
| Nutriband Inc. | 1.07 Million USD | -64554.158% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -6460.387% |
| Compugen Ltd. | 55.77 Million USD | -1150.679% |
| Roivant Sciences Ltd. | 773.95 Million USD | 9.87% |
| ProKidney Corp. | 29.21 Million USD | -2287.616% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -106357.668% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -51084.657% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -366.727% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2139.211% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -531.493% |
| Benitec Biopharma Inc. | 4.96 Million USD | -13958.162% |
| GeoVax Labs, Inc. | 3.51 Million USD | -19717.886% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2172.942% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2135.717% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2075.678% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -697.373% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -9888.058% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -341.937% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1965.638% |
| Imunon, Inc. | 8.53 Million USD | -8077.387% |
| BioAtla, Inc. | 48.98 Million USD | -1324.011% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -434.108% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4807.253% |
| Zura Bio Limited | 21.29 Million USD | -3176.188% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2107.697% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -196.567% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1341.193% |
| Galecto, Inc. | 5.89 Million USD | -11731.174% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3833.688% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 57.709% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -411.716% |
| PolyPid Ltd. | 17.46 Million USD | -3893.394% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -520.616% |
| Forte Biosciences, Inc. | 3.66 Million USD | -18927.987% |
| Xencor, Inc. | 283.55 Million USD | -146.004% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -18466.484% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -172604.18% |
| Instil Bio, Inc. | 99.8 Million USD | -598.957% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -46273.287% |
| OncoCyte Corporation | 49.29 Million USD | -1314.999% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1934.788% |
| Purple Biotech Ltd. | 10 Million USD | -6872.174% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -11956.101% |
| MacroGenics, Inc. | 154.2 Million USD | -352.357% |
| Verona Pharma plc | 58.84 Million USD | -1085.51% |
| Tharimmune, Inc. | 1.81 Million USD | -38332.414% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -3145.852% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4719.775% |
| Aditxt, Inc. | 28.53 Million USD | -2344.893% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -338524.272% |
| Savara Inc. | 37.19 Million USD | -1775.581% |
| Curis, Inc. | 57.61 Million USD | -1110.8% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1679.514% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -3250.622% |
| BeiGene, Ltd. | 2.23 Billion USD | 68.771% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -106357.668% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -9872.352% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -5377.12% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3986.503% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -378.214% |
| Adicet Bio, Inc. | 37.12 Million USD | -1779.219% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -385933.281% |
| Quantum-Si incorporated | 26.63 Million USD | -2519.376% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -22827.862% |
| Generation Bio Co. | 171.63 Million USD | -306.436% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1567.581% |
| Invivyd, Inc. | 51.71 Million USD | -1248.918% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -658.414% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -10623.122% |
| Moolec Science SA | 13.94 Million USD | -4902.138% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1297.088% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -7036.955% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -5620.192% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1220.123% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -88.606% |
| Evaxion Biotech A/S | 17.61 Million USD | -3859.511% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -333.462% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -3130.22% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1770.551% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2707.22% |
| Clearmind Medicine Inc. | 3.61 Million USD | -19223.115% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2461.944% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -730.179% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2964.913% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3375.492% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1744.827% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -624.766% |
| ImmunityBio, Inc. | 1.09 Billion USD | 36.026% |
| Korro Bio, Inc. | 51.75 Million USD | -1247.902% |
| Kineta, Inc. | 7.22 Million USD | -9558.903% |
| BioVie Inc. | 9.7 Million USD | -7089.823% |
| Codexis, Inc. | 49.94 Million USD | -1296.64% |
| Celularity Inc. | 102.92 Million USD | -577.716% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -201979.41% |
| Cibus, Inc. | 206.11 Million USD | -238.432% |
| Annexon, Inc. | 47.11 Million USD | -1380.466% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -623.826% |
| Eyenovia, Inc. | 19.78 Million USD | -3426.573% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -293.914% |
| NeurAxis, Inc. | 1.91 Million USD | -36369.482% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -7194.426% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -8267.11% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -28253.091% |
| Notable Labs, Ltd. | 4.42 Million USD | -15657.082% |
| IN8bio, Inc. | 8.77 Million USD | -7852.189% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -22380.374% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -844.431% |
| Lumos Pharma, Inc. | 13.33 Million USD | -5131.876% |
| Liquidia Corporation | 73.13 Million USD | -853.767% |
| Mustang Bio, Inc. | 17.61 Million USD | -3859.169% |
| Quantum-Si incorporated | 26.63 Million USD | -2519.376% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1717.383% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4719.775% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -28630.066% |
| 180 Life Sciences Corp. | 5.38 Million USD | -12848.56% |
| Vaxcyte, Inc. | 167.44 Million USD | -316.584% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1791.602% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -385933.281% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -827.935% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2857.293% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2964.913% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2908.825% |
| PepGen Inc. | 34.63 Million USD | -1914.282% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -5644.121% |
| Solid Biosciences Inc. | 38.45 Million USD | -1713.838% |
| Palisade Bio, Inc. | 2.73 Million USD | -25367.908% |
| Nutriband Inc. | 1.07 Million USD | -64554.158% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8981.708% |
| Immuneering Corporation | 12 Million USD | -5709.005% |
| Belite Bio, Inc | 4.21 Million USD | -16465.329% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -4707.153% |
| GeoVax Labs, Inc. | 3.51 Million USD | -19717.886% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -13179.383% |
| Altimmune, Inc. | 16.54 Million USD | -4117.194% |
| Peak Bio, Inc. | 20.75 Million USD | -3261.219% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3912.921% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -6500.738% |
| Neurogene Inc. | 36.54 Million USD | -1808.578% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -75.289% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -28430.307% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1363.937% |
| Sesen Bio, Inc. | 30.98 Million USD | -2151.375% |
| argenx SE | 444.95 Million USD | -56.774% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -827.935% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -6521.414% |
| Immunome, Inc. | 28.65 Million USD | -2334.106% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -29665.94% |
| Design Therapeutics, Inc. | 11.95 Million USD | -5734.443% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1691.939% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2586.977% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -256.377% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -263.208% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1154.721% |
| Athira Pharma, Inc. | 30.05 Million USD | -2220.81% |
| XOMA Corporation | 145.58 Million USD | -379.163% |
| Merus N.V. | 102.15 Million USD | -582.877% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -633.354% |
| Rezolute, Inc. | 11.73 Million USD | -5844.827% |
| Clene Inc. | 38.95 Million USD | -1690.881% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -24398.521% |
| BeyondSpring Inc. | 48.26 Million USD | -1345.164% |
| Synlogic, Inc. | 32.89 Million USD | -2020.584% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -4673.599% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -42590.698% |
| Peak Bio, Inc. | 20.75 Million USD | -3261.219% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -999.239% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1656.474% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -85.206% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -600.586% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -161102.701% |
| MannKind Corporation | 721.36 Million USD | 3.299% |
| Ikena Oncology, Inc. | 22.33 Million USD | -3023.197% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -33340.364% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -579.955% |
| Gossamer Bio, Inc. | 249.14 Million USD | -179.982% |
| CohBar, Inc. | 1.03 Million USD | -67386.489% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -6426.017% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3562.148% |
| Legend Biotech Corporation | 589.93 Million USD | -18.245% |
| Mural Oncology plc | 37.92 Million USD | -1739.185% |
| Disc Medicine, Inc. | 22.87 Million USD | -2949.469% |
| Champions Oncology, Inc. | 28.03 Million USD | -2388.197% |
| REGENXBIO Inc. | 262.22 Million USD | -166.015% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -20664.898% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -5465.39% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -5093.459% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -3189.63% |
| Vaxart, Inc. | 34.02 Million USD | -1950.157% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -3321.242% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2344.865% |
| Cellectis S.A. | 249.57 Million USD | -179.502% |
| Longeveron Inc. | 5.33 Million USD | -12970.377% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1568.06% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 70.998% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1055.523% |
| Revolution Medicines, Inc. | 262.39 Million USD | -165.844% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -33007.072% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -7986.784% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -5811.075% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4867.357% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -32329.847% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 86.455% |
| Denali Therapeutics Inc. | 122.96 Million USD | -467.297% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -12435.117% |
| Veru Inc. | 32.81 Million USD | -2025.902% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -10055.277% |
| Cingulate Inc. | 10.36 Million USD | -6632.7% |
| Passage Bio, Inc. | 39.26 Million USD | -1676.695% |
| Context Therapeutics Inc. | 4.19 Million USD | -16541.542% |
| Exicure, Inc. | 8.54 Million USD | -8059.621% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2263.989% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -6552.356% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -3064.856% |
| Nuvalent, Inc. | 31.82 Million USD | -2092.018% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -10865.214% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1006.861% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3775.367% |
| OmniAb, Inc. | 87.4 Million USD | -698.13% |
| Anew Medical, Inc. | 8.24 Million USD | -8363.759% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1721.84% |
| Lipocine Inc. | 2.63 Million USD | -26407.004% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2555.169% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1634.721% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2518.313% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -709.673% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -12815.497% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -743.011% |
| Ocugen, Inc. | 23.98 Million USD | -2808.585% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1403.148% |
| Q32 Bio Inc. | 233.12 Million USD | -199.22% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -7594.308% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1203.813% |
| Equillium, Inc. | 27.95 Million USD | -2395.139% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -237.654% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -12297.504% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -11274.036% |
| Dominari Holdings Inc. | 4.63 Million USD | -14949.968% |
| Edesa Biotech, Inc. | 1.84 Million USD | -37777.497% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2259.272% |
| Bio-Techne Corporation | 744.34 Million USD | 6.284% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -453.189% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -102.512% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1619.201% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2308.972% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -655.269% |
| Nkarta, Inc. | 105.6 Million USD | -560.574% |
| BioCardia, Inc. | 4.59 Million USD | -15097.516% |
| Iterum Therapeutics plc | 32.66 Million USD | -2035.711% |